科研
教育
解决方案
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Cell and Molecular Pharmacology and Experimental Therapeutics,
Hollings Cancer Center
Russell Spencer-Smith has not added Biography.
If you are Russell Spencer-Smith and would like to personalize this page please email our Author Liaison for assistance.
Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo.
Oncogene Apr, 2019 | Pubmed ID: 30573767
Correction: Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo.
Oncogene May, 2019 | Pubmed ID: 30710144
Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.
Cell reports Feb, 2022 | Pubmed ID: 35139380
Medical University of South Carolina
National Cancer Institute-Frederick
Russell Spencer-Smith1,2,3
1Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina,
2Hollings Cancer Center, Medical University of South Carolina,
3Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute-Frederick
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。